Therapy-related myeloid neoplasms: when genetics and environment collide
Nature Reviews Cancer 17, 513 (2017).
doi:10.1038/nrc.2017.60
Authors: Megan E. McNerney, Lucy A. Godley & Michelle M. Le Beau
Therapy-related myeloid neoplasms (t-MN) arise as a late effect of chemotherapy and/or radiation administered for a primary condition, typically a malignant disease, solid organ transplant or autoimmune disease. Survival is measured in months, not years, making t-MN one of the most aggressive and lethal cancers.
Source: Nature Reviews Cancer - Category: Cancer & Oncology Authors: Megan E. McNerney Lucy A. Godley Michelle M. Le Beau Tags: Review Source Type: research
More News: Autoimmune Disease | Cancer | Cancer & Oncology | Chemotherapy | Environmental Health | Genetics | Transplants